Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

Cited by (367)

Items 101–200 of 367

1. Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study
   Mark W. Tenforde, Margaret Mokomane, Tshepo Botho Leeme, Nametso Tlhako, Katlego Tsholo, Tony Chebani, Anya Stephenson, Jemima Hutton, Hannah K Mitchell, Raju K K Patel et al. · 2019 · The Lancet Infectious Diseases
2. Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease
   Joseph N Jarvis, Mark W. Tenforde, Kwana Lechiile, Thandi Milton, Amber Boose, Tshepo Leeme, Leabaneng Tawe, Charles Waithaka Muthoga, Ivy Rukasha, Fredah Mulenga et al. · 2020 · Journal of Clinical Microbiology
3. Cryptococcosis: a model for the understanding of infectious diseases
   John R. Perfect · 2014 · Journal of Clinical Investigation
4. HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings
   Mark W. Tenforde, Rachel M. Wake, Tshepo Botho Leeme, Joseph N Jarvis · 2016 · Current Clinical Microbiology Reports
5. MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil
   Diego Fernando Silva Rocha, Kátia Santana Cruz, Carla Silvana da Silva Santos, Lizandra Stephanny Fernandes Menescal, João Ricardo da Silva Neto, Silviane Bezerra Pinheiro, Lucyane Mendes Silva, Luciana Trilles, João Vicente Braga de Souza · 2018 · PLoS ONE
6. Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study
   İ̇smail Necati Hakyemez, Hakan Erdem, Guillaume Béraud, Matas Lurdes, André Silva‐Pinto, C. Alexandru, Boaz Bishop, F. Mangani, Xavier Argemi, Mélanie Poinot et al. · 2017 · European Journal of Clinical Microbiology & Infectious Diseases
7. Cryptococcal meningitis in AIDS
   Andrej Spec, William G. Powderly · 2018 · Handbook of clinical neurology
8. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials
   Matthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, Abdu K Musubire, Lillian Tugume, Edwin Nuwagira, Mahsa Abassi, Kenneth Ssebambulidde, Edward Mpoza, Ruben Kiggundu et al. · 2020 · Clinical Infectious Diseases
9. Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis
   Mahsa Abassi, Ananta Shrikant Bangdiwala, Edwin Nuwagira, Kiiza Kandole Tadeo, Michael Okirwoth, Darlisha A Williams, Edward Mpoza, Lillian Tugume, Kenneth Ssebambulidde, Kathy Huppler Hullsiek et al. · 2020 · Clinical Infectious Diseases
10. Opportunistic Neurologic Infections in Patients with Acquired Immunodeficiency Syndrome (AIDS)
    Fritzie S Albarillo, Paul O’Keefe · 2016 · Current Neurology and Neuroscience Reports
11. Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis
    Lillian Tugume, Bożena M Morawski, Mahsa Abassi, Nathan C. Bahr, Reuben Kiggundu, Henry W. Nabeta, KH Hullsiek, Kabanda Taseera, Abdu K Musubire, Charlotte Schutz et al. · 2016 · HIV Medicine
12. Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality
    Musubire, Abdu Kisekka, Meya, David B., Rhein, Joshua, Meintjes, Graeme, Bohjanen, Paul R., Nuwagira, Edwin, Muzoora, Conrad, Boulware, David R., Hullsiek, Kathy Huppler, the COAT and ASTRO trial teams · 2018 · PLOS ONE
13. Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV‐Infected Individuals
    Allison L. Balasko, Yoav Keynan · 2018 · HIV Medicine
14. Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003–12
    Hui Qin Xing, Yuhua Ruan, Jenny H. Hsi, Wei Kan, Lingjie Liao, Xuebing Leng, Jing Wang, Cui He, Yiming Shao, on behalf of the National HIVDR Working Group · 2015 · Journal of Antimicrobial Chemotherapy
15. Immune correlates of HIV-associated cryptococcal meningitis
    Mark W. Tenforde, James E. Scriven, Thomas Stephen Harrison, Joseph N Jarvis · 2017 · PLoS Pathogens
16. Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study
    Rudzani C Mashau, Susan T. Meiring, Vanessa Quan, Jeremy Stephen Nel, Greg Greene, Andrea Garcia, Colin Nigel Menezes, Denasha Lavanya Reddy, Michelle Venter, Sarah Lynn Stacey et al. · 2022 · The Lancet Infectious Diseases
17. Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas
    Liesbeth Vanherp, Jennifer Poelmans, Akila Weerasekera, Amy Hillen, A. Croitor Sava, Tania Christine Sorrell, Katrien Lagrou, Greetje Vande Velde, Uwe Himmelreich · 2020 · Translational research
18. Glucosamine stimulates pheromone-independent dimorphic transition in Cryptococcus neoformans by promoting Crz1 nuclear translocation
    Xinping Xu, Jianfeng Lin, Youbao Zhao, Elyssa Kirkman, Yee-Seul So, Yong‐Sun Bahn, Xiaorong Lin · 2017 · PLoS Genetics
19. Cryptococcal meningitis epidemiology: 17 years of experience in a State of the Brazilian Pantanal
    Joslaine de Oliveira Nunes, Rosianne Assis de Sousa Tsujisaki, Maína de Oliveira Nunes, Gláucia Moreira Espíndola Lima, Anamaria Mello Miranda Paniago, Elenir Rose Jardim Cury Pontes, Marilene Rodrigues Chang · 2018 · Revista da Sociedade Brasileira de Medicina Tropical
20. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial
    Mooketsi Molefi, Awilly A Chofle, Síle F. Molloy, Samuel Elias Kalluvya, John M. Changalucha, Francesca Cainelli, Tshepo Leeme, Nametso Lekwape, Drew W. Goldberg, Miriam R. Haverkamp et al. · 2015 · Trials
21. Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis
    John W. Baddley, George R. Thompson, Kristen Owen Riley, Mary K. Moore, Stephen A. Moser, Peter G. Pappas · 2019 · Open Forum Infectious Diseases
22. Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx
    Hyunah Yoon, Uriel R. Felsen, Tao Wang, Liise‐anne Pirofski · 2019 · Medical Mycology
23. Cryptococcosis in HIV/AIDS patients in northern Brazil: Clinical aspects, molecular types and isolation of agents from environmental samples associated with patients
    Marla Jalene Alves, Izabella Sadalla do Nascimento, Kátia Santana Cruz, Victoria Violeta Fernandes Menescal, Lizandra Stephanny Fernandes Menescal, Larissa Svetlana Cavalcante Silva, Silviane Bezerra Pinheiro, Aline Stephanie Pérez-Gómez, João Vicente Braga de Souza, Márcia dos Santos Lazéra et al. · 2022 · Tropical Medicine & International Health
24. Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report
    Jayne P. Ellis, Newton L. Kalata, Elizabeth C. Joekes, Samuel D. Kampondeni, Laura A. Benjamin, Thomas Stephen Harrison, David Griffith Lalloo, Robert S. Heyderman · 2018 · BMC Infectious Diseases
25. AIDS-associated Talaromyces marneffei central nervous system infection in patients of southwestern China
    Yu‐Ye Li, Rong‐Jing Dong, Samip Shrestha, Pratishtha Upadhyay, Huiqin Li, Yi‐Qun Kuang, Xinping Yang, Yungui Zhang · 2020 · AIDS Research and Therapy
26. Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
    Enock Kagimu, Nicole Wyman Engen, Kenneth Ssebambulidde, John Kasibante, Tadeo K Kiiza, Edward Mpoza, Lillian Tugume, Edwin Nuwagira, Laura Nsangi, Darlisha A Williams et al. · 2022 · Open Forum Infectious Diseases
27. Mortality After Cryptococcal Infection in the Modern Antiretroviral Therapy Era
    Matthew A. Hevey, Rachel M. Presti, Jane A. O’Halloran, Lindsey Larson, Krunal Raval, William G. Powderly, Andrej Spec · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
28. Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding
    David R. Boulware, Maximilian von Hohenberg, Melissa A R Rolfes, Nathan C. Bahr, Joshua Rhein, Andrew Akampurira, Darlisha A Williams, Kabanda Taseera, Charlotte Schutz, Tami R. McDonald et al. · 2015 · Open Forum Infectious Diseases
29. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China
    Zhiyong Shen, Qiuying Zhu, Zhenzhu Tang, Stephen W. Pan, Heng Zhang, He Jiang, Yi Chen, Guanghua Lan, Hui Qin Xing, Lingjie Liao et al. · 2016 · Clinical Infectious Diseases
30. Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study
    Ying‐Kui Jiang, Ling‐Hong Zhou, Jia-Hui Cheng, Junhao Zhu, Yu Luo, Li Li, Min Zhu, Rong‐Sheng Zhu, Wenjia Qiu, Hua‐Zhen Zhao et al. · 2024 · Clinical Microbiology and Infection
31. Artificial intelligence-driven mobile interpretation of a semi-quantitative cryptococcal antigen lateral flow assay
    David Bermejo-Peláez, Ana Alastruey‐Izquierdo, Narda Medina, Daniel Capellán-Martín, Oscar Bonilla, Miguel Angel Luengo-Oroz, Juan L. Rodrı́guez-Tudela · 2024 · IMA Fungus
32. Chemokine and Cytokine Cascade Caused by Skewing of the Th1-Th2 Balance Is Associated with High Intracranial Pressure in HIV-Associated Cryptococcal Meningitis
    Lijun Xu, Yongzheng Guo, Yizhou Zhao, Yufan Xu, Xiuming Peng, Zongxing Yang, Ran Tao, Ying Huang, Yan Xu, Yaokai Chen et al. · 2019 · Mediators of Inflammation
33. Clinical Presentation, Aetiology, and Outcomes of Meningitis in a Setting of High HIV and TB Prevalence
    Keneuoe Hycianth Thinyane, Keanole Mofona Motsemme, Varsay Cooper · 2015 · Journal of Tropical Medicine
34. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay
    Claudia E. Frola, Liliana I. Guelfand, Gabriela Alejandra Blugerman, Edgardo G. Szyld, Sara C. Kaufman, Pedro Enrique Cahn, Omar Gustavo Sued, Hector Pérez · 2017 · PLoS ONE
35. High Burden of Cryptococcal Meningitis Among Antiretroviral Therapy–Experienced Human Immunodeficiency Virus–Infected Patients in Northern Uganda in the Era of “Test and Treat”: Implications for Cryptococcal Screening Programs
    Mark Okwir, Abigail Link, Joshua Rhein, John Stephen Obbo, James Okello, Betty Nabongo, Jimmy Alal, David B. Meya, Paul R. Bohjanen · 2022 · Open Forum Infectious Diseases
36. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study
    Junyan Qu, Jingwen Jiang, Xiaoju Lv · 2020 · BMC Infectious Diseases
37. Diagnostic Performance of Metagenomic Next-Generation Sequencing in Central Nervous System Cryptococcosis Using Cerebrospinal Fluid
    Xuan Zhang, Yaqing Lin, Huixin Chen, Jianhua Hu, Hong Zhao, Meifang Yang, Dongsheng Han · 2023 · Infection and Drug Resistance
38. Short‐course amphotericin B in addition to sertraline and fluconazole for treatment of HIV‐associated cryptococcal meningitis in rural Tanzania
    Andrew Katende, Gladys Mbwanji, Diana Faini, Amina Nyuri, Aneth Vedastus Kalinjuma, Dorcas Mnzava, Katherine Huppler Hullsiek, Joshua Rhein, Maja Weisser, David B. Meya et al. · 2019 · Mycoses
39. Variability in innate host immune responses to cryptococcosis
    Mariam Garelnabi, Robin C. May · 2018 · Memórias do Instituto Oswaldo Cruz
40. Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis
    Katharine Elizabeth Stott, Justin Beardsley, Ruwanthi Kolamunnage‐Dona, Anahi Santoyo Castelazo, Freddie Kibengo, Nguyen Thi Hoang, Nguyen Le Nhu Tung, Ngo Thi Kim Cuc, Jeremy Day, William W. Hope · 2018 · Antimicrobial Agents and Chemotherapy
41. Early clinical and microbiological predictors of outcome in hospitalized patients with cryptococcal meningitis
    Lidiane de Oliveira, Márcia de Souza Carvalho Melhem, Renata Buccheri, Oscar José Chagas, José Ernesto Vidal, Fredi Alexander Díaz-Quijano · 2022 · BMC Infectious Diseases
42. Cryptococcus neoformans Genotypic Diversity and Disease Outcome among HIV Patients in Africa
    Kennedy Kassaza, Fredrickson B Wasswa, Kirsten Nielsen, Joel Bazira · 2022 · Journal of Fungi
43. Rapid Microscopy and Use of Vital Dyes: Potential to Determine Viability of Cryptococcus neoformans in the Clinical Laboratory
    Brendan Joseph McMullan, Desmarini Desmarini, Julianne T. Djordjevic, Wen Chen, Michael P. V. Roper, Tania Christine Sorrell · 2015 · PLoS ONE
44. Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
    Tinevimbo Shiri, Angela Loyse, Lawrence Mwenge, Tao Chen, Shabir Lakhi, Duncan M Chanda, Peter Mwaba, Síle F. Molloy, Robert S. Heyderman, Cecilia Kanyama et al. · 2019 · Clinical Infectious Diseases
45. Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes
    Katelyn A Pastick, Ananta Shrikant Bangdiwala, Mahsa Abassi, Andrew G. Flynn, Bożena M Morawski, Abdu K Musubire, Prosperity C. Eneh, Charlotte Schutz, Kabanda Taseera, Joshua Rhein et al. · 2019 · Open Forum Infectious Diseases
46. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis
    Fátima Concha-Velasco, Elsa González-Lagos, Carlos Seas, Beatriz Bustamante · 2017 · PLoS ONE
47. Emerging and re‐emerging fungal threats in Africa
    Rachael Dangarembizi, Sean A Wasserman, Jennifer Claire Hoving · 2022 · Parasite Immunology
48. Enlarged periventricular space and periventricular lesion extension on baseline brain MRI predicts poor neurological outcomes in cryptococcus meningoencephalitis
    Woo Jin Lee, Young Jin Ryu, Jangsup Moon, Soon‐Tae Lee, Keun‐Hwa Jung, Kyung‐Il Park, Manho Kim, Sang Kun Lee, Kon Chu · 2021 · Scientific Reports
49. First report of urease activity in the novel systemic fungal pathogen Emergomyces africanus: a comparison with the neurotrope Cryptococcus neoformans
    Barbra Toplis, Chris Richard Kenyon, Ilan Steven Schwartz, Heinrich Kroukamp, Riaan N. de Witt, Nelesh Premapragasan Govender, Sybren de Hoog, Alfred Botha · 2017 · FEMS Yeast Research
50. Neurological Sequelae of Adult Meningitis in Africa: A Systematic Literature Review
    Drew W. Goldberg, Mark W. Tenforde, Hannah K Mitchell, Joseph N Jarvis · 2017 · Open Forum Infectious Diseases
51. Pharmacokinetics–pharmacodynamics of antifungal agents in the central nervous system
    Katharine Elizabeth Stott, William W. Hope · 2018 · Expert Opinion on Drug Metabolism & Toxicology
52. One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi
    Cecilia Kanyama, Síle F. Molloy, Adrienne Kit Chan, Duncan Lupiya, Chimwemwe Chawinga, Jack Adams, Philip Bright, David Griffith Lalloo, Robert S. Heyderman, Olivier Lortholary et al. · 2019 · Clinical Infectious Diseases
53. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure
    Min Li, Jia Liu, Xuhui Deng, Qingzhou Gan, Yijie Wang, Xiaofeng Xu, Ying Jiang, Fuhua Peng · 2020 · BMC Infectious Diseases
54. Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation
    Reuben Kiggundu, Joshua Rhein, David B. Meya, David R. Boulware, Nathan C. Bahr · 2014 · Medical Mycology Case Reports
55. Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020)
    Olivier Paccoud, Marie Desnos‐Ollivier, Florence Persat, Magalie Demar, Karine Sitbon, Anne‐Pauline Bellanger, Julie Bonhomme, Christine Bonnal, Françoise Botterel, Marie‐Elisabeth Bougnoux et al. · 2024 · Clinical Microbiology and Infection
56. Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis
    Seke G. Y. Muzazu, Dawit Getachew Assefa, Christabel Chigwe Phiri, Tewodros Getinet, Samrawit Solomon, Gizachew Yismaw, Tsegahun Manyazewal · 2022 · Frontiers in Medicine
57. Cryptococcus and Cryptococcosis in Cuba. A minireview
    María Teresa Illnait Zaragozí, Gerardo Martínez-Machín, Carlos Fernández Andreu, Mayda Rosa Perurena Lancha, Ferry Hagen, Jacques F. G. M. Meis · 2014 · Mycoses
58. B Cell Compartmentalization in Blood and Cerebrospinal Fluid of HIV-Infected Ugandans with Cryptococcal Meningitis
    Samuel Okurut, David B. Meya, Freddie Bwanga, Joseph Okao Olobo, Michael A. Eller, Fatim Cham-Jallow, Paul R. Bohjanen, Harsh Pratap, Brent E. Palmer, Katharine H. Hullsiek et al. · 2019 · Infection and Immunity
59. The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study
    Liang Sheng Wu, Xiao Jiang, Yangzi Song, Guiju Gao, Hongxin Zhao · 2020 · BMC Infectious Diseases
60. Clinical features and Outcomes of Cryptococcemia patients with and without HIV infection
    Handan Zhao, Minghan Zhou, Qing Zheng, Mingjian Zhu, Zongxing Yang, Caiqin Hu, Lijun Xu · 2021 · Mycoses
61. Very Low Levels of 25-Hydroxyvitamin D Are Not Associated With Immunologic Changes or Clinical Outcome in South African Patients With HIV-Associated Cryptococcal Meningitis
    Joseph N Jarvis, Tihana A. Bicanic, Angela Loyse, Graeme Meintjes, Louise E. Hogan, Chrissy h. Roberts, Shmuel Shoham, John R. Perfect, Nelesh Premapragasan Govender, Thomas Stephen Harrison · 2014 · Clinical Infectious Diseases
62. Unique clinical features of cryptococcal meningitis among Chinese patients without predisposing diseases against patients with predisposing diseases
    Lijun Xu, Xinyue Zhang, Yongzheng Guo, Ran Tao, Xiahong Dai, Zongxing Yang, Ying Huang, Biao Zhu, Yan Xu · 2018 · Medical Mycology
63. Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections
    Schiave, Letícia Aparecida, Nascimento, Erika, Vilar, Fernando Crivelenti, de Haes, Tissiana Marques, Takayanagui, Osvaldo Massaiti, Gaitani, Cristiane Masetto de, Martinez, Roberto · 2018 · The Brazilian Journal of Infectious Diseases
64. Neglected mycobiome in HIV infection: Alterations, common fungal diseases and antifungal immunity
    Shuang Li, Xiaodong Yang, Christiane Moog, Hao Wu, Bin Su, Tong Zhang · 2022 · Frontiers in Immunology
65. Cryptococcal disease in the solid organ transplant setting
    Noah Wald‐Dickler, Emily Blodget · 2017 · Current Opinion in Organ Transplantation
66. Genetic influence of Toll-like receptors on non-HIV cryptococcal meningitis: An observational cohort study
    Ying‐Kui Jiang, Jiqin Wu, Hua‐Zhen Zhao, Xuan Wang, Ruiying Wang, Ling‐Hong Zhou, Ching‐Wan Yip, Liping Huang, Jia-Hui Cheng, Yahong Chen et al. · 2018 · EBioMedicine
67. Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
    Caleb P Skipper, Katherine Huppler Hullsiek, Anna Stadelman, Darlisha A Williams, Kenneth Ssebambulidde, Elizabeth C Okafor, Lillian Tugume, Edwin Nuwagira, Andrew Akampurira, Abdu K Musubire et al. · 2022 · Journal of Fungi
68. Reframing the clinical phenotype and management of cryptococcal meningitis
    Maria Francisca Rocha, Hamish DC. Bain, Neil R. H. Stone, David B. Meya, Lucia Darie, Ahmed Kassem Toma, Michael Peter Lunn, Arpan R. Mehta, Charles Hamish Coughlan · 2024 · Practical Neurology
69. Flow Cytometry To Assess Cerebrospinal Fluid Fungal Burden in Cryptococcal Meningitis
    James E. Scriven, Lisa M. Graham, Charlotte Schutz, Thomas J. Scriba, Robert John Wilkinson, David R. Boulware, Graeme Meintjes, David Griffith Lalloo, Britta C. Urban · 2015 · Journal of Clinical Microbiology
70. Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
    Carlos Franco‐Paredes, Daniel B. Chastain, Alfonso Javier Rodriguez-Morales, Luis A. Marcos · 2017 · Annals of Clinical Microbiology and Antimicrobials
71. Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis
    Laura Lynn Kovanda, Charles D. Giamberardino, Laura McEntee, Dena L. Toffaletti, Kelly S. Franke, Andrew Bartuska, Gordon Smilnak, George C. de Castro, Katelyn Ripple, William W. Hope et al. · 2019 · Antimicrobial Agents and Chemotherapy
72. Predictors of in‐hospital mortality among HIV‐positive patients presenting with an acute illness to the emergency department
    Abdullah Ebrahim Laher, Fathima Paruk, WDF Venter, OA Ayeni, Guy A. Richards · 2021 · HIV Medicine
73. Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
    Ting Sheng Zhao, Xiao-Lei Xu, Jing-Min Nie, Xiao-Hong Chen, Zhongsheng Jiang, Shui-Qing Liu, Tongtong Yang, Xuan Yang, Feng Sun, Yanqiu Lu et al. · 2021 · BMC Infectious Diseases
74. Treatment Principles for Candida and Cryptococcus
    Laura Whitney, Tihana A. Bicanic · 2014 · Cold Spring Harbor Perspectives in Medicine
75. Pathogen and host genetics underpinning cryptococcal disease
    Carolina Coelho, Rhys A. Farrer · 2020 · Advances in genetics
76. Magnitude of Cryptococcosis among HIV patients in sub-Saharan Africa countries: a systematic review and meta-analysis
    Tsegaye Alemayehu, Sosina Ayalew, Temesgen Buzayehu, Deresse Daka · 2020 · African Health Sciences
77. Clinical Characteristics and Risk Factors for Mortality in Cryptococcal Meningitis: Evidence From a Cohort Study
    Fengjuan Wang, Yu Wang, Jian‐Qing He, Zhe Cheng, Shouquan Wu, Ming-Gui Wang, Ting Niu · 2022 · Frontiers in Neurology
78. Evaluation and management of the swollen optic disk in cryptococcal meningitis
    Mohammed Rigi, Khurrum Khan, Stacy V. Smith, Ayman Suleiman, Andrew G. Lee · 2016 · Survey of Ophthalmology
79. Cryptococcosis
    Aditi H. Jani, Ashleigh N Reigler, Sixto Manuel Leal, Todd P McCarty · 2024 · Infectious Disease Clinics of North America
80. Short-Course Induction Treatment with Intrathecal Amphotericin B Lipid Emulsion for HIV Infected Patients with Cryptococcal Meningitis
    Gerardo Alvarez‐Uria, Manoranjan Midde, Raghavakalyan Pakam, Pradeep Sukumar Yalla, Praveen Kumar Naik, Raghuprakash Reddy · 2015 · Journal of Tropical Medicine
81. Colliding Epidemics and the Rise of Cryptococcosis
    Christina C. Chang, Sharon Chia-Ju Chen · 2015 · Journal of Fungi
82. The Next Frontier in Neurocritical Care in Resource-Constrained Settings
    Madiha Raees, Beverly Cheserem, Benjamin Mutiso, Tsegazeab Laeke, Brian Jason Brotherton · 2022 · Critical Care Clinics
83. Immune Reconstitution Inflammatory Syndrome in HIV-Infected Immigrants
    María Pérez-Rueda, Michele Hernández-Cabrera, Adela Francés, Alfonso Ángel-Moreno, Elena Pisos-Álamo, Nieves Jaén‐Sánchez, Cristina Carranza‐Rodriguez, José-Luís Pérez-Arellano · 2017 · American Journal of Tropical Medicine and Hygiene
84. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study
    Li Xu, Jia Liu, Qilong Zhang, Min Li, Jingchi Liao, Weifeng Kuang, Cansheng Zhu, Huan Yi, Fuhua Peng · 2018 · Neurological Research
85. Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis
    Katharine Elizabeth Stott, Justin Beardsley, Sarah Whalley, Freddie Kibengo, Nguyen Thi Hoang, Nguyen Le Nhu Tung, Ngo Thi Kim Cuc, Ruwanthi Kolamunnage‐Dona, William W. Hope, Jeremy Day · 2018 · Antimicrobial Agents and Chemotherapy
86. Recent advances in managing HIV-associated cryptococcal meningitis
    Timothée Boyer‐Chammard, Elvis Temfack, Alexandre Alanio, Joseph N Jarvis, Thomas Stephen Harrison, Olivier Lortholary · 2019 · F1000Research
87. Management of HIV-associated cryptococcal disease in South Africa
    Nelesh Premapragasan Govender, Sipho Kenneth Dlamini · 2014 · South African Medical Journal
88. Cryptococcal infection: host immunity, immune evasion and emerging immunotherapeutic strategies
    Fei Li, Xin‐Xin Yu, Miao Li, Xiaoyu Ning, Kaijian Zhou · 2025 · Frontiers in Cellular and Infection Microbiology
89. The diagnosis of central nervous system infections in resource-limited settings and the use of novel and molecular diagnostic platforms to improve diagnosis
    James Milburn, Rachita Suresh, Ronan Doyle, Joseph N Jarvis · 2024 · Expert Review of Molecular Diagnostics
90. Comparison of Early Fungicidal Activity and Mortality Between Daily Liposomal Amphotericin B and Daily Amphotericin B Deoxycholate for Cryptococcal Meningitis
    Sarah Kimuda, Richard Kwizera, Biyue Dai, Enos Kigozi, Derrick Kasozi, Morris K Rutakingirwa, Asmus Tukundane, Nabbaale Shifah, Tony Luggya, Andrew Luswata et al. · 2024 · Clinical Infectious Diseases
91. Antigen Titers in Cryptococcal Meningitis: What Determines How Fast They Fall?
    John E. Bennett, Peter Richard Williamson · 2024 · The Journal of Infectious Diseases
92. Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis
    Síle F. Molloy, Brad Ross, Cecilia Kanyama, Sayoki Mfinanga, Sokoine Lesikari Kivuyo, Robert S. Heyderman, Newton L. Kalata, Jayne P. Ellis, Charles Kouanfack, Duncan M Chanda et al. · 2021 · Open Forum Infectious Diseases
93. Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient
    Rodrigo de Carvalho Santana, Letícia Aparecida Schiave, Alda Soares dos Santos Quaglio, Cristiane Masetto de Gaitani, Roberto Martínez · 2017 · Mycopathologia
94. Cross-Reacting Ustilago maydis Causing False-Positive Cryptococcal Antigen Test Results
    Matthew Pellan Cheng, Tien T. Nguyen, Leighanne Parkes, Philippe J. Dufresne, Donald C. Sheppard · 2017 · Journal of Clinical Microbiology
95. Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis
    John Diehl, Katherine Huppler Hullsiek, Michael Okirwoth, Nicole Stephens, Mahsa Abassi, Joshua Rhein, David B. Meya, David R. Boulware, Abdu K Musubire, ASTRO-CM Trial Team et al. · 2018 · Open Forum Infectious Diseases
96. Burden of acute kidney injury in HIV patients under deoxycholate amphotericin B therapy for cryptococcal meningitis and cost-minimization analysis of amphotericin B lipid complex
    Felipe Francisco Tuon, Khaiany Lino Florencio, Jaime Luís Lopes Rocha · 2018 · Medical Mycology
97. Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda
    Jonathan Kitonsa, Rebecca Namugabwe Nsubuga, Yunia Mayanja, Julius P. Kiwanuka, Yofesi Nikweri, Martin Onyango, Zacchaeus Anywaine, Abu-Baker Ggayi, Freddie Kibengo, Pontiano Kaleebu et al. · 2020 · PLoS neglected tropical diseases
98. Cryptococcal Meningoencephalitis in Phenotypically Normal Patients
    Pia Cumagun, Mary Katherine Moore, Todd P McCarty, Gerald McGwin, Peter G. Pappas · 2023 · Pathogens
99. Duration of systemic antifungal therapy for patients with invasive fungal diseases: A reassessment
    Simon B. Gressens, Claire Rouzaud, Frédéric Lamoth, Thierry Calandra, Fanny Lanternier, Olivier Lortholary · 2025 · Molecular Aspects of Medicine
100. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis
     ASTRO-CM Study Team, Ali A. Alhadab, Joshua Rhein, Lillian Tugume, Abdu K Musubire, Darlisha A Williams, Mahsa Abassi, Melanie R. Nicol, David B. Meya, David R. Boulware et al. · 2019 · Journal of Pharmacokinetics and Pharmacodynamics